NCT05263154

Brief Summary

The study aims at investigate whether low oxygen therapy during anesthesia improves oxygen partial pressure and lung function in the postoperative period after abdominal surgery. 200 patients scheduled for abdominal surgery will be randomized (1:1) to goal directed low oxygen concentration during and after anesthesia vs. fixed high oxygen concentration. Arterial oxygen partial pressure is the primary outcome and lung function a secondary explanatory outcome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
26 days until next milestone

Study Start

First participant enrolled

March 28, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

August 16, 2023

Status Verified

August 1, 2023

Enrollment Period

2.8 years

First QC Date

February 20, 2022

Last Update Submit

August 15, 2023

Conditions

Keywords

postoperative hypoxiaabdominal surgeryrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Mean change in arterial oxygen partial pressure after surgery vs. before surgery

    Oxygen partial pressure

    3 days

Secondary Outcomes (9)

  • Mean change in diffusion capacity for carbon-monoxide after surgery vs. before surgery

    3 days

  • Mean change in vital capacity after surgery vs. before surgery

    3 days

  • Mean change in forced expiratory volume in one second after surgery vs. before surgery

    3 days

  • Mean change in arterial carbon-dioxide partial pressure after surgery vs. before surgery

    3 days

  • Mean change in arterial oxygen partial pressure after surgery vs. before surgery

    3 months

  • +4 more secondary outcomes

Study Arms (2)

Goal directed low oxygen

EXPERIMENTAL

Oxygen given at low concentrations following goals of oxygen saturation during and after anesthesia

Other: Goal directed low oxygen

High oxygen

ACTIVE COMPARATOR

Oxygen given as traditionally including high concentrations

Other: High oxygen

Interventions

Oxygen is titrated until oxygen saturation is 100% in one-minute steps before the induction of anesthesia, with increasing fraction of inspired oxygen (FiO2) from 0.25 to 0.30 to 0.35 and so on. After intubation, the FiO2 is set to 0.25 to achieve a target saturation of 94-96%. Supplementary oxygen after surgery will be given with the same targets and with as little oxygen as necessary.

Goal directed low oxygen

FiO2 1.0 before induction until end-tidal oxygen concentrations of 0.80 occur. The FiO2 will be reduced to 0.35 during anesthesia, followed by an increase in FiO2 to 0.80 during 5 minutes before extubating the patient, followed by FiO2 0.40 for at least thirty minutes after anesthesia. Oxgen will then be given at 3 liters a minute with a oxygen saturation goal of 98%

High oxygen

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being scheduled for a major abdominal cancer surgery lasting for more than 2 hours.
  • Having a condition within American Society of Anesthesia Class 1-3.

You may not qualify if:

  • Being at risk for a difficult intubation during anesthesia in the form of Mallampati score 3-4, or having a previous documentation of difficult intubation.
  • Decline participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital

Umeå, SE 901 85, Sweden

RECRUITING

MeSH Terms

Conditions

Postoperative Complications

Interventions

high-potential iron-sulfur protein oxygen oxidoreductase

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Karl A Franklin, MD, PhD

    Umeå University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karl A Franklin, MD, Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Profesor, Consultant surgeon

Study Record Dates

First Submitted

February 20, 2022

First Posted

March 2, 2022

Study Start

March 28, 2022

Primary Completion

December 31, 2024

Study Completion

March 31, 2025

Last Updated

August 16, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Depends on what is allowed according to Swedish Ethical authority.

Locations